NIAGEN BIOSCIENCE, INC. Share-based Payment Arrangement, Expensed and Capitalized, Amount
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Payment Arrangement, Expensed and Capitalized, Amount of $7.00 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 · last filed 2019-08-07
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expensed and capitalized, amount for fiscal 2018 was $1.30M.
| Period end | Share-based Payment Arrangement, Expensed and Capitalized, Amount 6 month | Share-based Payment Arrangement, Expensed and Capitalized, Amount 12 month |
|---|---|---|
| 2019-06-30 | $7.00M 10-Q · filed 2019-08-07 | |
| 2018-12-31 | $1.30M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |